36C25022Q0304.docx

DOCX document 15 KB Posted

Attached to
6505--PYLARIFY Radiopharmaceutical Ann Arbor VAMC Nuclear Medicine Department
Solicitation number
36C25022Q0304
Issued by

View the file

Other files

File Type Posted
LSJ - Over Sat - CO.docx DOCX document

On GovTribe

Work with this file

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file

Text version

Special Notice Special Notice

SUBJECT*
PYLARIFY Radiopharmaceutical Ann Arbor VAMC Nuclear Medicine Department

GENERAL INFORMATION

CONTRACTING OFFICE’S ZIP CODE*
45409-1337
SOLICITATION NUMBER*
36C25022Q0304
ARCHIVE
30 DAYS AFTER THE RESPONSE DATE
RECOVERY ACT FUNDS
N
PRODUCT SERVICE CODE*
6505
NAICS CODE*
325412

CONTRACTING OFFICE ADDRESS

Department of Veterans Affairs Network Contracting Office (NCO) 10 3140 Governor’s Place Blvd. Suite 210 Kettering OH 45409-1337

POINT OF CONTACT*

Contract Specialist LouAnn Gilliland louann.gilliland@va.gov 937-268-6511

ADDITIONAL INFORMATION

AGENCY’S URL
https://www.va.gov
URL DESCRIPTION
VA Homepage
AGENCY CONTACT’S EMAIL ADDRESS
louann.gilliland@va.gov
EMAIL DESCRIPTION
Procurement Point of Contact

DESCRIPTION

The Department of Veterans Affairs, VHA Regional Procurement Office Central, Network Contracting Office 10, located at 3140 Governor’s Place Blvd., Suite 210, Kettering, OH 45409 intends to award a single-award, firm-fixed-priced FSS contract from 02/23/2022 until 09/30/2022 to Progenics Pharmaceuticals, Inc., a Lantheus company, address is at 1 World Trade CTR FL 47, New York, New York 10007-0089, United States. This award will be for the Nuclear Medicine Clinic at the Ann Arbor VAMC.

The acquisition is conducted under authority of the Multiple Award Schedule Program; FAR Subpart 8.405-6(b) Items Peculiar to one Manufacturer. The primary statutory authorities for the MAS program are 41 U.S.C. 152(3), Competitive Procedures, and 40 U.S.C. 501, Service for Executive Agencies. It is the Government’s belief the proposed candidate is the sole manufacturer capable of meeting the requirement. The associated North America Classification Systems (NAICS) Code is 325412 and the Small Business Size Standard is 1,250 employees.

It is the Government’s belief the proposed candidate is the only source with the required capabilities to successfully meet the requirement for PYLARIFY® (piflufolastat F 18) Injection, which is a radioactive diagnostic agent for men with prostate cancer. This is an FDA approved, proprietary item available only through the sole manufacturer and authorized supplier of PYLARIFY.

This notice satisfies the requirement at FAR 5.201(b)(1), to publicize the proposed contract action. This notice of intent is not a request for competitive proposals. No solicitation documents are available at this time. Interested parties may give written notice to LouAnn.Gilliland@va.gov by 5:00pm e.s.t. on February 25, 2022. Supporting evidence must be furnished in sufficient detail to demonstrate the ability to meet the subject requirement. This information shall be provided at no cost or obligation to the Government. Responses will be considered by the Government; however, a determination by the Government not to compete the proposed acquisition based upon responses of this notice is solely within the discretion of the Government.

Inquiries shall be emailed to LouAnn.Gilliland@va.gov. No telephone requests will be accepted. Any response to this notice must show clear and convincing evidence that competition would be advantageous to the Government in future procurements.

See attached document: LSJ - Over Sat - CO.

*= Required Field
Special Notice

Special Notice

File details come from the government source that posted it. Updated .